Supply of Epinephrine Injection (NDC: 00115-1694-49)

The contract specifies the manufacture and supply of FDA-compliant Epinephrine Injection with NDC 00115-1694-49 and NSN 6505016804416, in a strength of 3.000 PG, to be delivered to Fort Lewis, WA by August 20, 2026. The product must adhere to current Good Manufacturing Practices (cGMP) and comply with the Defense Priorities and Allocations System (DPAS) as well as the Defense Logistics Agency’s strict traceability standards to ensure full accountability and authenticity throughout the supply chain. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, and the NAICS code 325412 indicates the activity falls within pharmaceutical and medicine manufacturing. The requirement is tied to a specific delivery location and deadline, emphasizing the urgency and critical nature of the medical supply for military use. While the solicitation number and point of contact details are not provided, the contract is accessible through the DIBBS system via the provided link, which serves as the official record for award and fulfillment tracking. All aspects of production, packaging, labeling, and shipment must align with federal and military regulations to ensure compatibility with DoD medical logistics systems and readiness protocols.